Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours

Technology appraisal guidance
Reference number: TA265
Published: 24 October 2012

TA265 Bone metastases from solid tumours - denosumab: Appendix A provisional matrix of stakeholders

TA265 Bone metastases from solid tumours - denosumab: Appendix A provisional matrix of stakeholders

TA265 Bone metastases from solid tumours - denosumab: Appendix A provisional matrix of stakeholders
29 July 2013
(104.47 Kb 30 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 26 July 2013